NCR’s COVID-19 positivity rate exceeds 50% for the first time — OCTA | Inquirer News

NCR’s COVID-19 positivity rate exceeds 50% for the first time — OCTA

/ 03:22 PM January 09, 2022

MANILA, Philippines — The National Capital Region (NCR)’s COVID-19 positivity rate exceeded 50 percent for the first time, independent pandemic monitor Octa Research said on Sunday.

Octa Research fellow Dr. Guido David, however, noted that the rate of positivity rate increase “could be slowing down.”

“The positivity rate in the NCR was 50.5% as of January 7, 2022, the first time it exceeded 50% in the NCR,” David said on Twitter.

Article continues after this advertisement

“The data from DOH (Department of Health) shows that the rate of increase of the positivity rate could be slowing down,” he added.

Data in the following days will show if the positivity rate is “slowing down or if it is just an artificial effect,” the fellow said.

Article continues after this advertisement

Should the spike in positivity rate slow down, the peak of COVID-19 cases in Metro Manila might occur within the week, said David.

COVID-19 positivity rate refers to the number of people infected with SARS-CoV-2 — the virus that causes COVID-19 — among tested individuals.

The DOH on Saturday logged a 43.7-percent positivity rate, way above than the World Health Organization standard of five percent or less.

je
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS:  Guido David, COVID-19, OCTA Research

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.